The efficacy of smoking cessation strategies in people with chronic obstructive pulmonary disease: results from a systematic review

Respiratory Medicine: COPD Update - Tập 1 - Trang 29-39 - 2005
E.J. Wagena1, R.M. van der Meer2, R.J.W.G. Ostelo3, J.E. Jacobs4, C.P. van Schayck1
1Care and Public Health Research Institute (CAPHRI), Department of General Practice, Maastricht University, Maastricht, The Netherlands
2Stivoro—For a Smoke Free Future, The Hague, The Netherlands
3VU University Medical Centre, Amsterdam, The Netherlands
4Centre for Quality of Care Research, University of Nijmegen and Maastricht University, Nijmegen, The Netherlands

Tài liệu tham khảo

Pauwels, 2001, Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease NHLBI/WHO global initiative for chronic obstructive lung disease (GOLD) Workshop summary, Am J Respir Crit Care Med, 163, 1256, 10.1164/ajrccm.163.5.2101039 Roche, 1997, Current issues in the management of chronic obstructive pulmonary disease, Respirology, 2, 215, 10.1111/j.1440-1843.1997.tb00082.x US Department of Health and Human Services. The health consequences of smoking: chronic obstructive lung disease. Rockville, MD: Office on Smoking and Health, Department of Health and Human Services; 1984. Report No. (CDC) 8.416. Burchfiel, 1995, Effects of smoking and smoking cessation on longitudinal decline in pulmonary function, Am J Respir Crit Care Med, 151, 1778, 10.1164/ajrccm.151.6.7767520 Camilli, 1987, Longitudinal changes in forced expiratory volume in one second in adults, Am Rev Respir Dis, 135, 794, 10.1164/arrd.1987.135.4.794 Fletcher, 1976 Muers, 1999, Quitting smoking and lungs, Lancet, 354, 177, 10.1016/S0140-6736(99)90021-1 Pelkonen, 2001, Smoking cessation, decline in pulmonary function and total mortality: a 30 year follow up study among the Finnish cohorts of the seven countries study, Thorax, 56, 703, 10.1136/thx.56.9.703 Xu, 1992, Effects of cigarette smoking on rate of loss of pulmonary function in adults: a longitudinal assessment, Am Rev Respir Dis, 146, 1345, 10.1164/ajrccm/146.5_Pt_1.1345 Tashkin, 1994, The UCLA population studies of chronic obstructive respiratory disease: XI. Impact of air pollution and smoking on annual change in forced expiratory volume in one second, Am J Respir Crit Care Med, 149, 1209, 10.1164/ajrccm.149.5.8173761 Tager, 1988, The natural history of forced expiratory volumes: effect of cigarette smoking and respiratory symptoms, Am Rev Respir Dis, 138, 837, 10.1164/ajrccm/138.4.837 Anthonisen, 1994, Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. The Lung Health Study, JAMA, 272, 1497, 10.1001/jama.1994.03520190043033 Sherrill, 1994, Longitudinal analysis of the effects of smoking onset and cessation on pulmonary function, Am J Respir Crit Care Med, 149, 591, 10.1164/ajrccm.149.3.8118623 Soejima, 2000, Longitudinal follow-up study of smoking-induced lung density changes by high resolution computed tomography, Am J Respir Crit Care Med, 161, 1264, 10.1164/ajrccm.161.4.9905040 1995, Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease, Am J Respir Crit Care Med, 152, S77 BTS guidelines for the management of chronic obstructive pulmonary disease: the COPD guideline group of the standards of care committee of the BTS. Thorax 1997;52(suppl. 5):S1–28. Siafakas, 1995, Optimal assessment and management of chronic obstructive pulmonary disease (COPD). The European Respiratory Society Task Force, Eur Respir J, 8, 1398, 10.1183/09031936.95.08081398 Van der Meer R, Wagena EJ, Ostelo R, Jacobs J, Van Schayck CP. Smoking cessation for people with chronic obstructive pulmonary disease (Cochrane review). In: The Cochrane Library, Issue 2. Oxford: Update Software; 2003. Hughes JR, Stead LF, Lancaster T. Antidepressants for smoking cessation (Cochrane review). In: The Cochrane Library, Issue 2. Oxford: Update Software; 2002. Jarvis MJ, Powell SR, Marsh HS, Browning D, Aristides M, Brown A. A meta-analysis of clinical studies confirms the effectiveness of bupropion SR (Zyban™) in smoking cessation. Poster Presentation at the 8th Annual Meeting of the Society for Research on Nicotine and Tobacco, Savannah, Georgia, February 20–23, 2002. Perruchoud, 2002, The efficacy of bupropion hydrochloride sustained release (SR) for smoking cessation is consistent in placebo-controlled studies, Eur Respir J, 20, 579s Manheimer, 2002, Survey of public information about ongoing clinical trials funded by industry: evaluation of completeness and accessibility, BMJ, 325, 528, 10.1136/bmj.325.7363.528 McCray, 2000, Better access to information about clinical trials, Ann Intern Med, 133, 609, 10.7326/0003-4819-133-8-200010170-00013 Anderson, 2001, TrialsCentral, an online register of clinical trials registers, Control Clin Trials, 22, S40 Verhagen, 1998, The Delphi list: a criteria list for quality assessment of randomized clinical trials for conducting systematic reviews developed by Delphi consensus, J Clin Epidemiol, 51, 1235, 10.1016/S0895-4356(98)00131-0 Wintertree Software Inc. Review Manager 4.2.2. In: The Cochrane Collaboration; 2003. Crowley, 1995, Behavioral anti-smoking trial in chronic obstructive pulmonary disease patients, Psychopharmacology, 119, 193, 10.1007/BF02246161 Brandt, 1997, Effect of diagnosis of “smoker's lung”, Lancet, 349, 253, 10.1016/S0140-6736(05)64863-5 Pederson, 1991, The effects of counseling on smoking cessation among patients hospitalized with chronic obstructive pulmonary disease: a randomized clinical trial, Int J Addiction, 26, 107, 10.3109/10826089109056242 Tashkin, 2001, Smoking cessation in patients with chronic obstructive pulmonary disease: a double-blind, placebo-controlled, randomised trial, Lancet, 357, 1571, 10.1016/S0140-6736(00)04724-3 Murray, 2002, Persistence of the effect of the lung health study (LHS) smoking intervention over eleven years, Prev Med, 35, 314, 10.1006/pmed.2002.1087 Silagy C, Lancaster T, Stead L, Mant D, Fowler G. Nicotine replacement therapy for smoking cessation (Cochrane review). In: The Cochrane Library, Issue 2. Oxford: Update Software; 2002. Balfour, 2001, The pharmacology underlying pharmacotherapy for tobacco dependence: focus on bupropion, Int J Clin Pract, 55, 53 Scanlon, 2001, Smoking cessation: effects on symptoms, spirometry and future trends in COPD, Thorax, 56, ii7 Lancaster, 2000, Effectiveness of interventions to help people stop smoking: findings from the Cochrane library, BMJ, 321, 355, 10.1136/bmj.321.7257.355 Covey, 2000, Advances in non-nicotine pharmacotherapy for smoking cessation, Drugs, 59, 17, 10.2165/00003495-200059010-00003 Hughes, 2001, Distinguishing nicotine dependence from smoking Why it matters to tobacco control and psychiatry, Arch Gen Psychiatry, 58, 817, 10.1001/archpsyc.58.9.817